UWC-56433-32854
4 vaccinations
5 coded responses
43 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2021-05-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
F7Y-49759-88671
Child or adolescent in my care · Female · 2022-10-06
Timeline
-
2021-04-13
Dose 1 — Pfizer-BioNTech
-
2021-05-04
Dose 2 — Pfizer-BioNTech
-
2021-05-06
Registered in v-safe
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-20
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-08-03
- 2021-11-02
-
2021-12-09
Dose 3 — Pfizer-BioNTechCo-administered: Tetanus
- 2021-12-09
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-12-11
- 2021-12-12
-
2021-12-13
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis, Respiratory tract congestion, Sinusitis — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Congestion, like I'm coming down with a cold or sinus infectiknMedDRA releases: 2024-11 · check-in free text available
-
2021-12-14
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion, SARS-CoV-2 test positive — Feeling: Fair · Fever · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stuffy nose; tested positive for COVID-19 with an at-home antigen testMedDRA releases: 2024-11 · check-in free text available
-
2021-12-15
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion, Respiratory tract congestion — Feeling: FairFree text: Congestion/stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-16
Survey response — day 7, dose 3MedDRA: Nasal congestion, Respiratory tract congestion — Feeling: FairFree text: Congestion (stuffy nose), but improvingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-23
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-03-10
- 2022-06-09
-
2022-10-06
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-06
-
2022-10-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-20
-
2022-10-27
Survey response — day 21, dose 4MedDRA: Blepharitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: BlepharitisMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Report sent to call center — day 21, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-28
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2023-01-06
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | |
| 2 | 2021-05-04 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Pfizer-BioNTech | Tetanus |
| 4 | 2022-10-06 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-27 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Congestion, like I'm coming down with a cold or sinus infectikn
Systemic reaction (other): Stuffy nose; tested positive for COVID-19 with an at-home antigen test
Systemic reaction (other): Congestion/stuffy nose
Release 10 — day 7, dose 3
Systemic reaction (other): Congestion (stuffy nose), but improving
Release 12 — day 21, dose 4
Symptoms: Blepharitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blepharitis | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release